1. Academic Validation
  2. CXCR2, as a key regulatory gene of HDP-PG-1, maintains intestinal mucosal homeostasis

CXCR2, as a key regulatory gene of HDP-PG-1, maintains intestinal mucosal homeostasis

  • Int J Biol Macromol. 2024 May 3;269(Pt 2):132025. doi: 10.1016/j.ijbiomac.2024.132025.
Di Yan 1 Guoyang Wei 1 Zichun Ai 1 Shuang Song 1 Licong Zhang 1 Na Dong 1 Xiujing Dou 2 Anshan Shan 3
Affiliations

Affiliations

  • 1 College of Animal Science and Technology, Northeast Agricultural University, Harbin 150030, China.
  • 2 College of Animal Science and Technology, Northeast Agricultural University, Harbin 150030, China. Electronic address: douxiujing@neau.edu.cn.
  • 3 College of Animal Science and Technology, Northeast Agricultural University, Harbin 150030, China. Electronic address: asshan@neau.edu.cn.
Abstract

The intestine defends against pathogenic microbial invasion via the secretion of host defense Peptides (HDPs). Nutritional immunomodulation can stimulate the expression of endogenous HDPs and enhance the body's immune defense, representing a novel non-antibiotic strategy for disease prevention. The project aims to explore the regulatory mechanism of protegrin-1 (PG-1) expression using sodium phenylbutyrate (PBA) by omics Sequencing technology and further investigate the role of key regulatory genes on intestinal health. The results showed that PBA promoted PG-1 expression in intestinal epithelial cells based on cell density through epidermal growth factor receptor (EGFR) and G protein-coupled receptor (GPR43). Transcriptome Sequencing and microRNA Sequencing revealed that C-X-C motif Chemokine Receptor 2 (CXCR2) exhibited interactions with PG-1. Pre-treatment cells with a CXCR2 Inhibitor (SB225002) effectively suppressed the induction of PG-1 by PBA. Furthermore, SB225002 significantly suppressed the gene expression of HDPs in the jejunum of mice without influencing on the morphology, number of goblet cells, and proliferation of the intestine. CXCR2 inhibition significantly reduced the expression of HDPs during E. coli Infection, and resulted in the edema of jejunal epithelial cells. The 16S rDNA analysis of cecal contents showed that the E. coli and SB225002 treatments changed gut microbiota diversity and composition at different taxonomic levels. Correlation analysis suggested a potential regulatory relationship between gut microbiota and HDPs. To that end, a gene involved in the HDP expression, CXCR2, has been identified in the study, which contributes to improving intestinal immune function. PBA may be used as a functional additive to regulate intestinal mucosal function, thereby enhancing the health of the intestinal and host.

Keywords

CXCR2; Host defense peptide; Intestinal homeostasis; Sodium phenylbutyrate.

Figures
Products